Skip to main content
Aelis Farma logo

Aelis Farma — Investor Relations & Filings

Ticker · AELIS ISIN · FR0014007ZB4 LEI · 8945008D5R6WV7EXRN47 PA Manufacturing
Filings indexed 157 across all filing types
Latest filing 2024-06-04 AGM Information
Country FR France
Listing PA AELIS

About Aelis Farma

https://www.aelisfarma.com

Aelis Farma is a clinical-stage biopharmaceutical company that discovers and develops treatments for brain and central nervous system (CNS) disorders. The company has created a new class of drugs called Signaling Specific inhibitors of the CB1 receptor (CB1-SSi). This proprietary mechanism is designed to selectively inhibit the pathological signaling of the CB1 receptor, which is implicated in various brain diseases, while preserving its normal physiological functions and avoiding adverse effects associated with previous CB1-targeting drugs. The company's lead drug candidate, AEF0117, is in development for the treatment of Cannabis Use Disorder (CUD). Its second candidate, AEF0217, is being investigated for the treatment of cognitive deficits, including those associated with Down syndrome.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
AGM Information Classification · 99% confidence The document is explicitly titled "Results of Aelis Farma Combined General Meeting of June 4, 2024". It details that all resolutions recommended by the Board of Directors were adopted by the shareholders at this meeting, including the adoption of the 2023 financial statements and compensation policies. This content directly relates to the outcomes and materials presented at an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document length (4956 chars) is substantial enough to be the primary announcement, not just a brief RPA.
2024-06-04 English
Informations privilégiées / Autres communiqués
AGM Information Classification · 98% confidence The document is explicitly titled "Communication des résultats de l'Assemblée générale mixte d'Aelis Farma du 4 juin 2024" (Communication of the results of the Combined General Meeting of Aelis Farma of June 4, 2024). It confirms that all resolutions were adopted and mentions the approval of accounts and remuneration policies, which are typical items voted upon at an AGM. This directly corresponds to the definition of AGM Information (AGM-R). Although it mentions the results of the vote will be available later, the primary purpose of this press release is to announce the outcome and confirmation of the meeting itself.
2024-06-04 French
Modalités de mise à disposition des documents préparatoires à l'AG
AGM Information Classification · 98% confidence The document is explicitly titled "Assemblée générale mixte du 4 juin 2024 : mise à disposition des documents préparatoires et modalités de participation et de vote" (Mixed General Meeting of June 4, 2024: making preparatory documents available and participation and voting methods). It details the date, time, and location of the upcoming Annual General Meeting (AGM) and explains how shareholders can vote remotely or access related documents. This content directly relates to the preparation and execution of an AGM. Therefore, the appropriate classification is AGM Information (AGM-R). Although it mentions the availability of documents, the primary focus is the meeting itself, making AGM-R more specific than RPA or RNS.
2024-05-14 French
Terms of availability of the preparatory documents for the GM
AGM Information Classification · 98% confidence The document is explicitly titled 'Press release' and announces the details regarding the 'Combined General Meeting of June 4, 2024: Availability of preparatory documents and participation and voting procedures'. This content directly relates to the logistics, documentation, and procedures surrounding an Annual General Meeting (AGM). While it mentions the availability of documents, the primary focus is the announcement of the meeting itself and how shareholders can participate/vote, which aligns best with the AGM Information category (AGM-R). It is not the voting results (DVA) nor the proxy solicitation materials (PSI), but the announcement of the meeting and related preparatory documents.
2024-05-14 English
Annual financial and audit reports / Terms of availability of the annual financial report
Report Publication Announcement Classification · 98% confidence The document is explicitly titled "Availability of the 2023 Universal Registration Document" and is issued as a "Press release." It announces that the 2023 Universal Registration Document (URD) has been approved by the AMF and is now available for consultation on the company's website and the AMF website. The URD itself contains the annual financial report and auditor reports. Since this document is an announcement *about* the availability of a major regulatory filing (the URD, which is similar in scope to a 10-K but specific to certain European jurisdictions), and it is short (5035 characters) and directs the reader elsewhere for the full document, it fits the definition of a Report Publication Announcement (RPA). It is not the full 10-K or AR itself, but the notice of its release.
2024-04-25 English
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel
Report Publication Announcement Classification · 98% confidence The document is explicitly titled "Mise à disposition du Document d'Enregistrement Universel 2023" (Making available of the 2023 Universal Registration Document). It states that the document, approved by the AMF (Autorité des marchés financiers), is now available for consultation and download. The content listed within the DEU includes the annual financial report, auditor reports, and CSR information. Since the text itself is an announcement stating that the comprehensive annual filing (which resembles a 10-K in content scope, but is filed under the European Universal Registration Document format) has been published and provides links to access it, it fits the definition of a Report Publication Announcement (RPA) according to Rule 2 ("MENU VS MEAL" rule). While the underlying document is an annual filing, this specific text is the announcement of its availability.
2024-04-25 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.